ライフサイエンスコーパス: choriomeningitis

1 hat cause human diseases such as lymphocytic choriomeningitis, Bolivian hemorrhagic fever, and Lassa

2 murine gamma-herpesvirus 68 and lymphocytic choriomeningitis clone 13 and reversed T cell exhaustion

3 complexes formed during chronic lymphocytic choriomeningitis infection can interfere with Fcgamma-re

4 ion in humans and during chronic lymphocytic choriomeningitis infection in mice.

5 onstrated in vivo during chronic lymphocytic choriomeningitis infection.

6 , we focused on two RNA viruses: lymphocytic choriomeningitis (LCMV) and influenza (Flu).

7 tion, including the well-studied lymphocytic choriomeningitis (LCMV) and Pichinde (PICV) viruses, sev

8 s antigen tetramers and to LCMV (lymphocytic choriomeningitis)-reactive CD8+ T cells.

9 we have developed a recombinant lymphocytic choriomeningitis virus (LCMV) (rLCMVDeltaGP/GFP) where w

10 l known pathogenic arenaviruses, lymphocytic choriomeningitis virus (LCMV) and Lassa, Junin, Machupo,

11 C from the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) and LASV, which correlated

12 ith two natural mouse pathogens, lymphocytic choriomeningitis virus (LCMV) and murine cytomegalovirus

13 Prf1(--)) mice are infected with lymphocytic choriomeningitis virus (LCMV) and secondary (noninherite

14 e generated after infection with lymphocytic choriomeningitis virus (LCMV) and that these CD4 T cells

15 re we show that the arenaviruses lymphocytic choriomeningitis virus (LCMV) and the clinically used Ju

16 NPs) of the Old World arenavirus lymphocytic choriomeningitis virus (LCMV) and the New World arenavir

17 hmania major and 2 wk later with lymphocytic choriomeningitis virus (LCMV) and then monitored the cou

18 Mice were infected with lymphocytic choriomeningitis virus (LCMV) and treated with Mn(III)te

19 ections, such as infections with lymphocytic choriomeningitis virus (LCMV) and vaccinia virus, where

20 nrelated and pathogenic viruses, lymphocytic choriomeningitis virus (LCMV) and vaccinia virus.

21 In this study, using lymphocytic choriomeningitis virus (LCMV) and Zika virus (ZIKV) in w

22 endrocyte glycoprotein (MOG) and lymphocytic choriomeningitis virus (LCMV) antigens, respectively.

23 Using lymphocytic choriomeningitis virus (LCMV) as a model of a persistent

24 ion with a persistent variant of lymphocytic choriomeningitis virus (LCMV) but have no impact on vira

25 We show that lymphocytic choriomeningitis virus (LCMV) can also inhibit macrophag

26 Lymphocytic choriomeningitis virus (LCMV) can cause acute fatal dise

27 Lymphocytic choriomeningitis virus (LCMV) can establish acute or chr

28 f life-long chronic infection by lymphocytic choriomeningitis virus (LCMV) Cl 13 but does not affect

29 infection with HIV in humans or lymphocytic choriomeningitis virus (LCMV) clone 13 in mice.

30 ly induced on APCs at day 2 post-lymphocytic choriomeningitis virus (LCMV) clone 13 infection, but is

31 T cells from mice infected with lymphocytic choriomeningitis virus (LCMV) clone 13 into recipient mi

32 During chronic infection with lymphocytic choriomeningitis virus (LCMV) clone 13, miR-31-deficent

33 with that of a persistent virus, lymphocytic choriomeningitis virus (LCMV) clone 13, on early innate

34 urs after mice are infected with lymphocytic choriomeningitis virus (LCMV) clone 13, which is used as

35 Lymphocytic choriomeningitis virus (LCMV) clone 13, which normally e

36 ersistent infection of mice with lymphocytic choriomeningitis virus (LCMV) clone 13.

37 ic event are more susceptible to lymphocytic choriomeningitis virus (LCMV) clone-13 infection exhibit

38 mice with Coxsackie virus B3 or lymphocytic choriomeningitis virus (LCMV) delayed diabetes onset and

39 mice persistently infected with lymphocytic choriomeningitis virus (LCMV) exhibit a severe defect in

40 we found that mice infected with lymphocytic choriomeningitis virus (LCMV) exhibit global perturbatio

41 eficient animals failed to clear lymphocytic choriomeningitis virus (LCMV) from hematopoietic organs

42 unized with H(2)O(2)-inactivated lymphocytic choriomeningitis virus (LCMV) generated cytolytic, multi

43 d mice with Ad5 vectors encoding lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP) and exam

44 denovirus vectors expressing the lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP), followe

45 d35, and Ad48 vectors expressing lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP).

46 wever, the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) has proven to be a Rosetta

47 and CD8(+) T cells responding to lymphocytic choriomeningitis virus (LCMV) identified multiple genes

48 acute primary infection with the lymphocytic choriomeningitis virus (LCMV) in mice is significantly f

49 itis B and C virus in humans and lymphocytic choriomeningitis virus (LCMV) in mice.

50 dotyped with the glycoprotein of lymphocytic choriomeningitis virus (LCMV) in vitro.

51 nges the outcome to a subsequent lymphocytic choriomeningitis virus (LCMV) infection and can result i

52 rus-specific CTLs during chronic lymphocytic choriomeningitis virus (LCMV) infection and suppressed C

53 fied during chronic versus acute lymphocytic choriomeningitis virus (LCMV) infection and suppresses T

54 Although much is known about lymphocytic choriomeningitis virus (LCMV) infection and the subseque

55 f IAPs in T-cell immunity during lymphocytic choriomeningitis virus (LCMV) infection by pharmacologic

56 hough cellular immunity to acute lymphocytic choriomeningitis virus (LCMV) infection has been well ch

57 ction over the course of chronic lymphocytic choriomeningitis virus (LCMV) infection in an IL-10 repo

58 In contrast to MCMV, lymphocytic choriomeningitis virus (LCMV) infection in mice seems to

59 e to establishment of persistent lymphocytic choriomeningitis virus (LCMV) infection in mice through

60 on of CD8 T cells during chronic lymphocytic choriomeningitis virus (LCMV) infection in mice.

61 ade during an acute or a chronic lymphocytic choriomeningitis virus (LCMV) infection in mice.

62 Lymphocytic choriomeningitis virus (LCMV) infection induces robust t

63 Using the lymphocytic choriomeningitis virus (LCMV) infection model, we show t

64 Using acute and chronic lymphocytic choriomeningitis virus (LCMV) infection models, we deter

65 Recently, several cases of fatal lymphocytic choriomeningitis virus (LCMV) infection occurred in tran

66 n kinetics and viral loads after lymphocytic choriomeningitis virus (LCMV) infection of Ctx(-) mice.

67 ramatic at 2 to 4 days following lymphocytic choriomeningitis virus (LCMV) infection of mice and can

68 We show here that persistent lymphocytic choriomeningitis virus (LCMV) infection of mice lacking

69 we used a mouse model of chronic lymphocytic choriomeningitis virus (LCMV) infection to address this

70 rom aseptic meningitis following lymphocytic choriomeningitis virus (LCMV) infection to hemorrhagic f

71 CD8(+) T-cell response to acute lymphocytic choriomeningitis virus (LCMV) infection was predominantl

72 erentiated CD8(+) T cells during lymphocytic choriomeningitis virus (LCMV) infection, and Blimp-1 def

73 during the first week of chronic lymphocytic choriomeningitis virus (LCMV) infection, before severe d

74 are essential for clearance of a lymphocytic choriomeningitis virus (LCMV) infection, but the virus c

75 t al. report that in response to lymphocytic choriomeningitis virus (LCMV) infection, fully different

76 During persistent lymphocytic choriomeningitis virus (LCMV) infection, IFNalpha and IF

77 ormation following immunization, lymphocytic choriomeningitis virus (LCMV) infection, or herpes simpl

78 pathology during early systemic lymphocytic choriomeningitis virus (LCMV) infection, suggesting a ho

79 In response to lymphocytic choriomeningitis virus (LCMV) infection, the immunosuppr

80 exhaustion in mice with chronic lymphocytic choriomeningitis virus (LCMV) infection.

81 cation in the context of chronic lymphocytic choriomeningitis virus (LCMV) infection.

82 uction at late stages of chronic lymphocytic choriomeningitis virus (LCMV) infection.

83 de in the mouse model of chronic lymphocytic choriomeningitis virus (LCMV) infection.

84 the manifestations of HLH after lymphocytic choriomeningitis virus (LCMV) infection.

85 lls are virus specific following lymphocytic choriomeningitis virus (LCMV) infection.

86 tion in vitro and in vivo during lymphocytic choriomeningitis virus (LCMV) infection.

87 HLH-like disease severity after lymphocytic choriomeningitis virus (LCMV) infection.

88 istributed prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) is a neglected human patho

89 istributed prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) is a neglected human patho

90 istributed prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) is a neglected human patho

91 istributed prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) is an important neglected

92 The prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) is widely used as a model

93 hronic Clone 13 (C13) strains of lymphocytic choriomeningitis virus (LCMV) led to two distinct phases

94 Ins2-GP(Tg) mice injected with lymphocytic choriomeningitis virus (LCMV) lost islet sympathetic ner

95 tion with the clone 13 strain of lymphocytic choriomeningitis virus (LCMV) or influenza virus.

96 of the Old World (OW) arenavirus lymphocytic choriomeningitis virus (LCMV) or Lassa virus, bind to RI

97 In mice infected with lymphocytic choriomeningitis virus (LCMV) or Listeria monocytogenes

98 C (BMDC) that were infected with lymphocytic choriomeningitis virus (LCMV) or loaded with an immunodo

99 at infection of mice with either lymphocytic choriomeningitis virus (LCMV) or pneumonia virus of mice

100 tion with the systemic pathogens lymphocytic choriomeningitis virus (LCMV) or vaccinia virus (VACV).

101 using RIP-LCMV mice expressing a lymphocytic choriomeningitis virus (LCMV) protein in the beta-cells.

102 low-dose infection of mice with lymphocytic choriomeningitis virus (LCMV) results in massive expansi

103 ation after acute infection with lymphocytic choriomeningitis virus (LCMV) strain Armstrong.

104 tigen variant-expressing chronic lymphocytic choriomeningitis virus (LCMV) strains, we uncovered that

105 mice persistently infected with lymphocytic choriomeningitis virus (LCMV) suppressed multiple Fcgamm

106 The lymphocytic choriomeningitis virus (LCMV) system constitutes one of

107 stently infected from birth with lymphocytic choriomeningitis virus (LCMV) to demonstrate that therap

108 e used the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) to develop a general molec

109 nant engineering of trisegmented lymphocytic choriomeningitis virus (LCMV) to express two genes of in

110 prototypic Old World arenavirus lymphocytic choriomeningitis virus (LCMV) to interfere with RIG-I/MA

111 ity of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) to interfere with the indu

112 viral nucleoprotein (NP) gene of lymphocytic choriomeningitis virus (LCMV) was expressed in the thymu

113 NP) of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) with the least frequently

114 NP of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV), as well as those of the h

115 y molecule expression induced by lymphocytic choriomeningitis virus (LCMV), CD28/B7-mediated costimul

116 prototype member in the family, lymphocytic choriomeningitis virus (LCMV), disables the host innate

117 rf1(-/-)) mice are infected with lymphocytic choriomeningitis virus (LCMV), disease is driven by over

118 The prototypic arenavirus, lymphocytic choriomeningitis virus (LCMV), is a model for dissecting

119 stributed prototypic arenavirus, lymphocytic choriomeningitis virus (LCMV), is a neglected human path

120 ting mice with L. guyanensis and lymphocytic choriomeningitis virus (LCMV), or the sand fly-transmitt

121 The prototypic arenavirus, lymphocytic choriomeningitis virus (LCMV), provides investigators wi

122 ding Ebola virus, Marburg virus, lymphocytic choriomeningitis virus (LCMV), rabies virus, and Lassa v

123 Lymphocytic choriomeningitis virus (LCMV), the prototype arenavirus,

124 in memory phase challenged with lymphocytic choriomeningitis virus (LCMV), which we show in this stu

125 T(M) from lymphocytic choriomeningitis virus (LCMV)-immune and H60-vaccinated

126 is also partially controlled in lymphocytic choriomeningitis virus (LCMV)-immune C57BL/6J mice throu

127 (AP)-fed controls, LP feeding in lymphocytic choriomeningitis virus (LCMV)-immune mice resulted in a

128 In this environment, lymphocytic choriomeningitis virus (LCMV)-infected iFRCs activated n

129 Here, we show that lymphocytic choriomeningitis virus (LCMV)-specific CD8(+) T cells ca

130 Here, we show that lymphocytic choriomeningitis virus (LCMV)-specific CD8+ T cells in n

131 sion of CCL21 in murine spleens, lymphocytic choriomeningitis virus (LCMV)-specific T cell responses

132 vivo during acute infection with lymphocytic choriomeningitis virus (LCMV).

133 at replicate the negative-strand lymphocytic choriomeningitis virus (LCMV).

134 ged with the Armstrong strain of lymphocytic choriomeningitis virus (LCMV).

135 against viral infection, such as lymphocytic choriomeningitis virus (LCMV).

136 fected with the mouse arenavirus lymphocytic choriomeningitis virus (LCMV).

137 e and infected the chimeras with lymphocytic choriomeningitis virus (LCMV).

138 tosis (HLH) after infection with lymphocytic choriomeningitis virus (LCMV).

139 ASP-deficient (WAS KO) mice with lymphocytic choriomeningitis virus (LCMV).

140 ponse to many viruses, including lymphocytic choriomeningitis virus (LCMV).

141 n mice chronically infected with lymphocytic choriomeningitis virus (LCMV).

142 n-deficient mice is triggered by lymphocytic choriomeningitis virus (LCMV).

143 on for the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).

144 II molecules were infected with lymphocytic choriomeningitis virus (LCMV).

145 ed after systemic infection with lymphocytic choriomeningitis virus (LCMV).

146 R signals after clearance of the lymphocytic choriomeningitis virus (LCMV).

147 h vaccinia virus (VV) but not to lymphocytic choriomeningitis virus (LCMV).

148 rine model of chronic infection, lymphocytic choriomeningitis virus (LCMV).

149 n mice chronically infected with lymphocytic choriomeningitis virus (LCMV).

150 s following acute infection with lymphocytic choriomeningitis virus (LCMV).

151 cular stomatitis virus (VSV) and lymphocytic choriomeningitis virus (LCMV).

152 e against infection with chronic lymphocytic choriomeningitis virus (LCMV).

153 ing acute infection of mice with lymphocytic choriomeningitis virus (LCMV).

154 ent of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).

155 ector T cells postinfection with lymphocytic choriomeningitis virus (LCMV).

156 th a variant glycoprotein of the lymphocytic choriomeningitis virus (LCMV-GP), creating a replicating

157 urine cytomegalovirus (MCMV) and lymphocytic choriomeningitis virus (LCMV; Cl13), in their natural ro

158 Lymphocytic choriomeningitis virus (LCVM) nucleoprotein (NP) counter

159 ollowed by replication-defective lymphocytic choriomeningitis virus (rLCMV) boost elicited robust CD4

160 We constructed recombinant lymphocytic choriomeningitis virus (rLCMV) featuring either addition

161 nts of the prototypic arenavirus lymphocytic choriomeningitis virus (rLCMVs), whose S-IGRs were repla

162 on CD8(+) T cells during chronic lymphocytic choriomeningitis virus and hepatitis C virus infections.

163 s also required for infection of lymphocytic choriomeningitis virus and human parainfluenza virus typ

164 expand and to protect from acute lymphocytic choriomeningitis virus and Leishmania major parasite inf

165 cribe its use in the contexts of lymphocytic choriomeningitis virus and Mycobacterium tuberculosis in

166 ell responses to infections with lymphocytic choriomeningitis virus and the intracellular bacteria Li

167 marenaviruses, the widely spread lymphocytic choriomeningitis virus and the recently described Wenzho

168 ve CD8+ T cells recognizing both lymphocytic choriomeningitis virus and vaccinia virus antigens.

169 us and EBV in humans and between lymphocytic choriomeningitis virus and vaccinia virus in mice.

170 n H-2K(b) carrying peptides from lymphocytic choriomeningitis virus and vaccinia virus, and used thes

171 f a naive C57BL/6 recipient with lymphocytic choriomeningitis virus and vaccinia virus, followed by c

172 owed enhanced viral clearance in lymphocytic choriomeningitis virus and vesicular stomatitis virus in

173 rtantly, anti-CD137 treatment of lymphocytic choriomeningitis virus Armstrong infected Stat3 conditio

174 administered at the beginning of lymphocytic choriomeningitis virus Armstrong infection anti-CD137 in

175 expression in vivo during acute lymphocytic choriomeningitis virus Armstrong infection, which induce

176 Using lymphocytic choriomeningitis virus Armstrong to probe the response t

177 ed by acute viral infection with lymphocytic choriomeningitis virus Armstrong.

178 Ns, and in persistently infected lymphocytic choriomeningitis virus carrier mice, which contain low l

179 T cells during acute and chronic lymphocytic choriomeningitis virus challenges, but did not affect th

180 Pathogenic HIV or lymphocytic choriomeningitis virus chronic infections display a pers

181 or nonhematopoietic cells during lymphocytic choriomeningitis virus clone 13 (LCMV CL-13) infection.

182 that the Old World arenaviruses lymphocytic choriomeningitis virus clone 13 (LCMV Cl13) and Lassa vi

183 ist chronic viral infection with lymphocytic choriomeningitis virus clone 13 (LCMV cl13).

184 d prevented chronic infection in lymphocytic choriomeningitis virus clone 13- and reduced viral load

185 The G protein from lymphocytic choriomeningitis virus endowed VSV with the ability to s

186 ns expressing well-characterized lymphocytic choriomeningitis virus epitopes, we found that survival

187 adenovirus vector expressing the lymphocytic choriomeningitis virus glycoprotein (LCMVgp) (Ad5gp) inc

188 Infection with lymphocytic choriomeningitis virus induces monopoiesis in wild-type

189 ne responses to acute and chronic lymphocyte choriomeningitis virus infection are regulated by type 1

190 normal acute response (day 8) to lymphocytic choriomeningitis virus infection but generated an increa

191 with this finding, we show that lymphocytic choriomeningitis virus infection can directly modulate t

192 e with rapamycin following acute lymphocytic choriomeningitis virus infection enhanced not only the q

193 responses to acute or persistent lymphocytic choriomeningitis virus infection in IFN-lambdaR1-deficie

194 ls are comparable in controlling lymphocytic choriomeningitis virus infection in mice and suppress gr

195 TGF-beta receptor during chronic lymphocytic choriomeningitis virus infection in mice, and determined

196 cell dysfunction during chronic lymphocytic choriomeningitis virus infection in mice, and PD-1(hi) c

197 In a model of chronic lymphocytic choriomeningitis virus infection in mice, we show that e

198 levels of memory following acute lymphocytic choriomeningitis virus infection in mice.

199 pecific CD8 T cells during acute lymphocytic choriomeningitis virus infection in mice.

200 c effects of IL-7 during chronic lymphocytic choriomeningitis virus infection in mice.

201 During lymphocytic choriomeningitis virus infection in vivo, PYK2 deficienc

202 (+) T cell subpopulations in the lymphocytic choriomeningitis virus infection model, we found that th

203 a murine model of HLH, involving lymphocytic choriomeningitis virus infection of perforin-deficient m

204 sic manner early following acute lymphocytic choriomeningitis virus infection to suppress the magnitu

205 ss of vaccination against lethal lymphocytic choriomeningitis virus infection using plasmid DNA in a

206 ntiviral immune responses, acute lymphocytic choriomeningitis virus infection was used.

207 show that during chronic murine lymphocytic choriomeningitis virus infection, activation of AKT and

208 ced viral clearance in models of lymphocytic choriomeningitis virus infection, and also protection fr

209 ring the early stages of chronic lymphocytic choriomeningitis virus infection, and that this early T

210 in immunization; however, during lymphocytic choriomeningitis virus infection, B cells induce T(FH) d

211 In chronic lymphocytic choriomeningitis virus infection, blockade of type I IFN

212 Upon lymphocytic choriomeningitis virus infection, Cmah(-/-) mice make mo

213 gulated during memory to chronic lymphocytic choriomeningitis virus infection, limiting functional ca

214 Following acute lymphocytic choriomeningitis virus infection, memory CD8 T cells in

215 in response to vaccinia virus or lymphocytic choriomeningitis virus infection, more Ag-specific memor

216 the experimental mouse model of lymphocytic choriomeningitis virus infection, we demonstrate that th

217 Following lymphocytic choriomeningitis virus infection, we found most killer c

218 (+) T cells to acute and chronic lymphocytic choriomeningitis virus infection, we show that memory ce

219 CD4 T cells at days 2 to 3 after lymphocytic choriomeningitis virus infection, when type I IFN levels

220 ls to mount a robust response to lymphocytic choriomeningitis virus infection, with both quantitative

221 reased cytokine production after lymphocytic choriomeningitis virus infection, yet DGK-deficient memo

222 nd in mouse liver within 24 h of lymphocytic choriomeningitis virus infection.

223 nd defective immune responses to lymphocytic choriomeningitis virus infection.

224 e or different times after acute lymphocytic choriomeningitis virus infection.

225 ctor CD8 T cells following acute lymphocytic choriomeningitis virus infection.

226 function in viral clearance upon lymphocytic choriomeningitis virus infection.

227 iles and chromatin states during lymphocytic choriomeningitis virus infection.

228 l generation and responses after lymphocytic choriomeningitis virus infection.

229 by Tim-3 and PD-1 during chronic lymphocytic choriomeningitis virus infection.

230 loping HLH immunopathology after lymphocytic choriomeningitis virus infection.

231 d the ability to contain chronic lymphocytic choriomeningitis virus infection.

232 ion to those in acute or chronic lymphocytic choriomeningitis virus infection.

233 ecific CD8(+) T cells during RRV-lymphocytic choriomeningitis virus infection.

234 RM subsets was overcome by acute lymphocytic choriomeningitis virus infection; nevertheless, memory v

235 y also show that chronic HIV and lymphocytic choriomeningitis virus infections have a very different

236 responding to acute and chronic lymphocytic choriomeningitis virus infections.

237 d were unable to resolve chronic lymphocytic choriomeningitis virus infections.

238 tion during primary responses to lymphocytic choriomeningitis virus lowered the magnitude of CD8 Ag-s

239 ve upon this, we used the murine lymphocytic choriomeningitis virus model and adenoviral vectors to c

240 ivation was also verified in the lymphocytic choriomeningitis virus model, in which IFN-beta promoter

241 by two other NS RNA viruses, the lymphocytic choriomeningitis virus of the Arenaviridae family and hu

242 the impact of an infection with lymphocytic choriomeningitis virus on prenatal allospecific toleranc

243 protracted viral infection with lymphocytic choriomeningitis virus or during autoimmune diabetes dev

244 cell cycle after infection with lymphocytic choriomeningitis virus or vesicular stomatitis virus.

245 r stomatitis virus, reovirus, or lymphocytic choriomeningitis virus replication but protected against

246 ot acute, infection of mice with lymphocytic choriomeningitis virus results in a marked expansion of

247 ction of Spi6 knockout mice with lymphocytic choriomeningitis virus revealed impaired survival of CD8

248 is cell turnover, we transferred lymphocytic choriomeningitis virus specific memory CD8 T cells into

249 ponses in mice given variants of lymphocytic choriomeningitis virus that cause acute or persisting in

250 in mice lacking B cells, whereas lymphocytic choriomeningitis virus titers were dramatically increase

251 We infected FtDKO mice with lymphocytic choriomeningitis virus to generate and track Ag-specific

252 gainst representative Old World (lymphocytic choriomeningitis virus) and New World (Junin virus) aren

253 detected in cells infected with lymphocytic choriomeningitis virus, an ambisense RNA virus, and minu

254 for vesicular stomatitis virus, lymphocytic choriomeningitis virus, and dengue virus but not for the

255 llaris, Cryptococcus neoformans, lymphocytic choriomeningitis virus, and West Nile virus.

256 found that in mice infected with lymphocytic choriomeningitis virus, colocalization of virus-specific

257 After infection of mice with lymphocytic choriomeningitis virus, IL-2Ralpha-deficient effector CD

258 murine CMV (MCMV), but not with lymphocytic choriomeningitis virus, induce CD25 on NK cells, along w

259 mice with Coxsackie virus B3 or lymphocytic choriomeningitis virus, neither of which directly destro

260 iciently promote CD8 immunity to lymphocytic choriomeningitis virus, nor did cav-1(-/-) OT-1(+) CD8(+

261 ss-reactive with three different lymphocytic choriomeningitis virus, one Pichinde virus, or one other

262 After infection with lymphocytic choriomeningitis virus, pearl mice developed all key fea

263 phase of an acute infection with lymphocytic choriomeningitis virus, we found that virus-specific CD8

264 fluenza hemagglutinin or GP from lymphocytic choriomeningitis virus, which enter through late endosom

265 The clone 13 (Cl13) variant of lymphocytic choriomeningitis virus--a prototype of Old World arenavi

266 es occur upon stimulation with a lymphocytic choriomeningitis virus-derived escape mutant as demonstr

267 ring splenocytes from individual lymphocytic choriomeningitis virus-immune donors into paired recipie

268 of panniculitis are observed in lymphocytic choriomeningitis virus-immune mice after vaccinia virus

269 es development in the CD8-driven lymphocytic choriomeningitis virus-induced model of type 1 diabetes.

270 dual role in the development of lymphocytic choriomeningitis virus-induced, T cell-mediated hepatiti

271 e highly dynamic model system of lymphocytic choriomeningitis virus-mediated hepatitis and bone marro

272 ther germinal center B cells nor lymphocytic choriomeningitis virus-specific Ab levels were influence

273 fic human CD8 T cells or chronic lymphocytic choriomeningitis virus-specific CD8 T cells from mice; 3

274 ty (approximately 65% to 80%) of lymphocytic choriomeningitis virus-specific CD8 T cells in lymphoid

275 al T-cell functions, "exhausted" lymphocytic choriomeningitis virus-specific cells losing the capacit

276 nsion of both primary and memory lymphocytic choriomeningitis virus-specific CTL, which could be corr

277 cells and the systemic levels of lymphocytic choriomeningitis virus-specific IgG2 Abs were dramatical

278 rom peripheral T cells using the lymphocytic choriomeningitis virus-specific P14 TCR.

279 ection, Cmah(-/-) mice make more lymphocytic choriomeningitis virus-specific T cells than WT mice, an

280 gnaling blockade on the residual lymphocytic choriomeningitis virus-triggered CTL response detected i

281 ing acute infection of mice with lymphocytic choriomeningitis virus.

282 response to acute infection with lymphocytic choriomeningitis virus.

283 tion during acute infection with lymphocytic choriomeningitis virus.

284 highly disseminating variant of lymphocytic choriomeningitis virus.

285 alitis from organ donor-acquired lymphocytic choriomeningitis virus.

286 iral immunity after infection by lymphocytic choriomeningitis virus.

287 ty to mount a recall response to lymphocytic choriomeningitis virus.

288 mice persistently infected with lymphocytic choriomeningitis virus.

289 N1; measles; dengue; rabies; and lymphocytic choriomeningitis virus.

290 ell immunity by using the murine lymphocytic choriomeningitis virus.

291 s, including West Nile virus and lymphocytic choriomeningitis virus.

292 tions after acute infection with lymphocytic choriomeningitis virus.

293 th the prototypic mouse pathogen lymphocytic choriomeningitis virus.

294 ion of mice with viruses such as lymphocytic choriomeningitis virus.

295 -type mice to four epitopes from lymphocytic choriomeningitis virus.

296 express the gp33-41 epitope from lymphocytic choriomeningitis virus.

297 nses during acute infection with lymphocytic choriomeningitis virus.

298 y ablated in T cells, with acute lymphocytic choriomeningitis virus.

299 on in response to infection with lymphocytic choriomeningitis virus.

300 derived from the glycoprotein of lymphocytic choriomeningitis virus.